Literature DB >> 36127956

Sarcoidosis and Its Dermatological Manifestations: A Narrative Review.

Jancy Koneti1, Swathi Priya Cherukuri2, Sai Gadde1, Revanth Kalluru1, Rahul Chikatimalla1, Thejaswi Dasaradhan2.   

Abstract

Sarcoidosis is an enigma diagnosed by ruling out other etiologies of granulomatous inflammation. The multisystem manifestations of sarcoidosis and the clinical polymorphism pose a diagnostic challenge to all physicians. The skin is the most commonly affected organ after the lungs in sarcoidosis. Dermatological manifestations can appear before, during, or after systemic involvement, and the type of skin lesion can have prognostic significance. Also, a biopsy of skin lesions is less invasive and more accessible to perform than a biopsy of visceral organs. Thus, in certain ways, cutaneous manifestations can aid in the diagnosis and prognosis of systemic disease. This article has focused on the frequently encountered skin lesions of sarcoidosis along with their prevalence, clinical features, and management.
Copyright © 2022, Koneti et al.

Entities:  

Keywords:  cutaneous sarcoidosis; erythema nodosum; lupus pernio; sarcoidosis; subcutaneous nodules

Year:  2022        PMID: 36127956      PMCID: PMC9481194          DOI: 10.7759/cureus.28053

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  67 in total

Review 1.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

2.  Cutaneous Sarcoidosis: Report of Two Cases.

Authors:  S Grover; P S Murthy; P K Kar; V Tewari; T C Shivyogi; R Manjunath
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

Authors:  E Neville; A N Walker; D G James
Journal:  Q J Med       Date:  1983

4.  Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

Authors:  B A Rybicki; M C Iannuzzi; M M Frederick; B W Thompson; M D Rossman; E A Bresnitz; M L Terrin; D R Moller; J Barnard; R P Baughman; L DePalo; G Hunninghake; C Johns; M A Judson; G L Knatterud; G McLennan; L S Newman; D L Rabin; C Rose; A S Teirstein; S E Weinberger; H Yeager; R Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

5.  Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans.

Authors:  Michael C Iannuzzi; Mary J Maliarik; Laila M Poisson; Benjamin A Rybicki
Journal:  Am J Respir Crit Care Med       Date:  2003-02-13       Impact factor: 21.405

Review 6.  Cutaneous Sarcoidosis.

Authors:  Karolyn A Wanat; Misha Rosenbach
Journal:  Clin Chest Med       Date:  2015-09-26       Impact factor: 2.878

7.  Cutaneous sarcoidosis in Caucasians.

Authors:  N K Veien; D Stahl; H Brodthagen
Journal:  J Am Acad Dermatol       Date:  1987-03       Impact factor: 11.527

8.  Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.

Authors:  M Carlesimo; S Giustini; A Rossi; P Bonaccorsi; S Calvieri
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

Review 9.  Skin manifestations of sarcoidosis.

Authors:  Juan Mañá; Joaquim Marcoval
Journal:  Presse Med       Date:  2012-05-09       Impact factor: 1.228

10.  Neurosarcoidosis.

Authors:  David Lacomis
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.